COMPREHENSIVE HEALTHCARE SYS (CHS.CA) Stock Fundamental Analysis

Name: COMPREHENSIVE HEALTHCARE SYS (CHS) Stock
Brand: COMPREHENSIVE HEALTHCARE SYS
Rating: 5 (3 reviews)

Canada - TSX Venture Exchange - TSX-V:CHS - CA2046632071 - Common Stock

0.65 CAD

+0.01 (+1.56%)

Last: 1/23/2026, 7:00:00 PM

Fundamental Rating

Taking everything into account, CHS scores 0 out of 10 in our fundamental rating. CHS was compared to 9 industry peers in the Health Care Technology industry. Both the profitability and financial health of CHS have multiple concerns. CHS is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CHS has reported negative net income.
In the past year CHS has reported a negative cash flow from operations.

1.2 Ratios

The Return On Assets of CHS (-127.36%) is worse than 66.67% of its industry peers.

		Industry Rank	Sector Rank
ROA	-127.36%
ROE	N/A
ROIC	N/A

ROA(3y)-235.23%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 60.93%, CHS is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of CHS has grown nicely.
The Profit Margin and Operating Margin are not available for CHS so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	60.93%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y21.64%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CHS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CHS remains at a similar level compared to 1 year ago.
The debt/assets ratio for CHS is higher compared to a year ago.

2.2 Solvency

CHS has an Altman-Z score of -38.88. This is a bad value and indicates that CHS is not financially healthy and even has some risk of bankruptcy.
CHS has a Altman-Z score of -38.88. This is in the lower half of the industry: CHS underperforms 66.67% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-38.88

ROIC/WACCN/A

WACC9.07%

2.3 Liquidity

A Current Ratio of 0.06 indicates that CHS may have some problems paying its short term obligations.
CHS has a Current ratio of 0.06. This is amonst the worse of the industry: CHS underperforms 88.89% of its industry peers.
A Quick Ratio of 0.06 indicates that CHS may have some problems paying its short term obligations.
With a Quick ratio value of 0.06, CHS is not doing good in the industry: 88.89% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	0.06
Quick Ratio	0.06

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 83.03% over the past year.
Looking at the last year, CHS shows a decrease in Revenue. The Revenue has decreased by -1.73% in the last year.
Measured over the past years, CHS shows a decrease in Revenue. The Revenue has been decreasing by -5.71% on average per year.

EPS 1Y (TTM)83.03%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-114%

Revenue 1Y (TTM)-1.73%

Revenue growth 3Y-5.71%

Revenue growth 5YN/A

Sales Q2Q%14.27%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.